Name the Remaining Problem
Identify the target and the impurity, variant, fragment, aggregate, or small molecule that controls acceptance.
Choose and develop separations that use hydrophobicity, coupled interaction mechanisms, or restricted pore access. This hub connects mechanism with ligand chemistry, salt and solvent selection, peptide purification, multimodal screening, hydroxyapatite, core-shell impurity capture, and polishing-step design.
Identify the target and the impurity, variant, fragment, aggregate, or small molecule that controls acceptance.
Choose hydrophobic, ionic, size-based, or combined interactions that distinguish the critical species.
Screen pH, salt, organic solvent, modifier, load, flow, wash, and elution within the target's stability window.
Measure recovery, impurity clearance, activity, aggregation, pressure, pool volume, robustness, and lifecycle.
| Mode | Dominant basis | Typical operation | Primary caution |
|---|---|---|---|
| HIC | Hydrophobic association promoted by suitable salts in aqueous buffer | Bind at higher salt and elute by decreasing salt or changing conditions | Salt can precipitate or alter proteins; ligand strength is medium-specific |
| Reversed phase | Strong hydrophobic partitioning to a nonpolar phase | Bind in aqueous mobile phase and elute with increasing organic solvent | Organic solvent and low pH may disrupt folded proteins |
| Mixed mode | Two or more interactions from one stationary-phase architecture | Bind-and-elute, flow-through, or weak partitioning | Behavior cannot be predicted from pI or hydrophobicity alone |
| Ceramic hydroxyapatite | Calcium-site and phosphate-site interactions on a crystalline surface | Selective binding and elution with phosphate, salt, pH, or combinations | Chelators and phosphate strongly alter retention; empirical screening is essential |
| Restricted-access core-shell multimodal | Large target excluded by shell while smaller impurities enter and bind internally | Flow-through polishing | Impurity capacity and target-size exclusion—not SEC resolution—control performance |
| Conventional SEC | Differential access to nonbinding pores | Isocratic size fractionation | Limited load volume and productivity for high resolution |
| Decision | Minimum evidence | Additional industrial evidence |
|---|---|---|
| HIC ligand and salt | Target and impurity retention, recovery, precipitation check, gradient map | Dynamic capacity, feed-lot robustness, salt handling, cleaning and lifetime |
| Reversed-phase peptide method | Peak identity, purity, recovery, gradient selectivity, solvent stability | Loading, solvent recovery, fraction handling, scale mixing and residual solvent strategy |
| Mixed-mode medium | Mechanistic condition map and full mass balance | Impurity-capacity challenge, robustness, cleaning, supply and documentation |
| Hydroxyapatite method | Phosphate, salt and pH effects; target quality and recovery | Particle handling, pressure, cleaning compatibility, cycle study and waste strategy |
| Polishing platform | Critical-impurity clearance and usable yield | Productivity, pool volume, buffer transitions, economics and failure response |
Each guide addresses a distinct decision so the cluster progresses from hydrophobic-mode selection to ligand and mobile-phase design, specialized multimodal mechanisms, and whole-process polishing choices.
Compare two hydrophobic separations by mobile phase, binding mechanism, biomolecule integrity, resolution, scale, and downstream fit.
Screen ligand chemistry and density without assuming that ligand name alone predicts hydrophobic strength or selectivity.
Select loading and elution salts by protein stability, salting-out strength, selectivity, solubility, process fit, and measured conductivity.
Develop peptide purification around stationary-phase chemistry, pore access, organic gradient, modifier, loading, recovery, and product stability.
Use coupled ionic, hydrophobic, hydrogen-bonding, or affinity-like interactions when single-mode selectivity is insufficient.
Understand calcium- and phosphate-mediated surface interactions and develop selective protein, aggregate, and nucleic-acid separations.
Distinguish restricted-access impurity-capture media from nonbinding size exclusion and select the appropriate flow-through or fractionation mechanism.
Choose polishing chromatography from the remaining impurity, product state, feed conditions, recovery, scale, and process economics.
Share the target, remaining impurity profile, feed buffer, scale, stability limits, current chromatogram, and required purity. Our team can review candidate media and a focused screening plan.
For research or industrial raw materials only. Suitability should be evaluated for the intended molecule, process, quality requirements, and operating conditions.